Warren Shlomchik Email

Co-Founder . BlueSphere Bio

Current Roles

Employees:
61
Revenue:
$9.5M
About
BlueSphere Bio was founded to unlock the potential of personalized T cell therapy for the treatment of cancer by harnessing the unique specificity of each patient’s own T cells for the particular molecular fingerprint of each patient’s own cancer through our novel TCXpress technology. Our proprietary TCXpress platform is an elegant, rapid approach that exploits the patient’s own immune defenses to attack their cancer specifically, and is designed to leave normal tissues untouched, thereby reducing harmful side effects. The platform and implementation allows us to deliver rapid, personalized T cell treatments for a variety of cancer indications.
BlueSphere Bio Address
350 Technology Drive
Pittsburgh, PA
United States
BlueSphere Bio Email

Past Companies

BlueSphere BioCo-Founder
University of Pittsburgh, UPMCProfessor, Director of Hematopoietic Stem Cell Transplantation and Cellular Therapies, Heme
Yale University School of MedicineProfessor of Medicine

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.